Analysis of oncogenes, tumor suppressor genes, autocrine growth‐factor production, and differentiation state of human osteosarcoma cell lines
- 1 November 1995
- journal article
- research article
- Published by Wiley in Molecular Carcinogenesis
- Vol. 14 (3) , 170-178
- https://doi.org/10.1002/mc.2940140306
Abstract
Human osteosarcoma and fibrosarcoma cell lines were investigated for alterations in oncogenes, tumor suppressor genes, and growth factors, all of which have been implicated in tumor formation. Characterization of oncogenes that are involved in osteosarcoma formation, including the c‐fos and c‐myc oncogenes, indicated that all six osteosarcoma cell lines examined had 5‐ to 20‐fold amplification of the c‐myc oncogene, whereas neither of two fibrosarcoma cell lines had c‐myc amplification. Interestingly, only three of six osteosarcoma cell lines displayed altered c‐myc immediate‐early gene function. c‐fos was found to be normal, both at the gene and functional levels, in all six osteosarcoma and both fibrosarcoma cell lines tested. Characterization of two tumor suppressor genes, p53 and RB1, that have been implicated in osteosarcoma formation indicated that p53 was altered in five of six osteosarcoma cell lines, whereas RB1 was altered in only two of six of these cell lines. Neither RB1 nor p53 was found to be altered in the fibrosarcoma cell lines tested. An additional transformation marker, autocrine growth‐factor production, was observed in all six osteosarcoma cell lines and both fibrosarcoma cell lines examined. Finally, the differentiation state of the osteosarcoma cell lines was investigated via the bone differentiation markers alkaline phosphatase and osteocalcin. Alkaline phosphatase activity was observed in four of six osteosarcoma cell lines but not in the two fibrosarcoma cell lines examined. The alkaline phosphatase activity was a result of the expression of the bone/liver/kidney alkaline phosphatase isoform. High‐level osteocalcin expression was observed in one of the osteosarcoma cell lines but not in the two fibrosarcoma cell lines examined, although all cell lines demonstrated low‐level osteocalcin expression. Together, these data demonstrate that relatively undifferentiated osteosarcomas commonly display c‐myc amplification, p53 and RBI mutation, and autocrine growth‐factor production, all of which may play a role in osteosarcomagenesis. © 1995 Wiley‐ Liss, Inc.Keywords
This publication has 30 references indexed in Scilit:
- Growth factor responsiveness and alterations in growth factor homeostasis in Syrian hamster embryo cells during in vitro transformationCarcinogenesis: Integrative Cancer Research, 1994
- p53 Sweeps Through Cancer ResearchScience, 1993
- Molecular characterization of the retinoblastoma susceptibility geneBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1993
- A death in the life of p53Nature, 1993
- Bone Morphogenetic Protein-2 Causes Commitment and Differentiation in C3Hl0T1/2 and 3T3 CellsGrowth Factors, 1993
- Correlation between lack of bone Gla protein mRNA expression in rat transplantable osteosarcomas and expression of both c‐fos and c‐jun proto‐oncogenesMolecular Carcinogenesis, 1993
- myc FUNCTION AND REGULATIONAnnual Review of Biochemistry, 1992
- The p53 tumour suppressor geneNature, 1991
- TGF-β stimulation and inhibition of cell proliferation: New mechanistic insightsCell, 1990
- The retinoblastoma gene and cell growth controlTrends in Biochemical Sciences, 1990